Medical News Today -
19 Dec 2013 18:00
New research details an experimental vaccine that could help improve the survival of patients with a lethal brain tumor called glioblastoma mutiforme, compared with standard care alone. This is according to a study published in the journal Neuro-Oncology.According to the American Association of Neurological Surgeons, glioblastoma mutiforme (GBM) accounts for around 15% of all brain tumors, with onset being most common between the ages of 45 and 70.
Share this Article